Chugai Pharmaceutical at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Chugai Pharmaceutical brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans. Chugai Pharmaceutical's program centres on turning cyclic peptides into drug products. Its work covers an amorphous solid dispersion that lets a macrocyclic peptide be taken by mouth, and how crystals of a clinical cyclic peptide take up water.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Chugai Pharmaceutical Tokyo, Japan | |
Japanese pharmaceutical company in the Roche group developing antibody, small-molecule and mid-size peptide medicines. | Poster Mon Oct 26 9:30am–10:30am Enabling Oral Delivery of a Macrocyclic Peptide through Amorphous Solid Dispersion Poster Mon Oct 26 11:30am–12:30pm Non-stoichiometric Hydration Behavior and Its Characterization of the Clinical Cyclic Peptide AUBE00 Crystals |
Instantly find 20 buyers from Chugai Pharmaceutical
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction